SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-04-003881
Filing Date
2004-08-09
Accepted
2004-08-09 15:14:36
Documents
4
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. b51110aie10vq.htm 10-Q 318814
2 EX-10.1 EMPLOYMENT AGREEMENT PETER THORNTON b51110aiexv10w1.txt EX-10.1 75607
3 EX-31.1 SECT. 302 C.E.O. CERTIFICATION b51110aiexv31w1.txt EX-31.1 3530
4 EX-32.1 SECT. 906 C.E.O. CERTIFICATION b51110aiexv32w1.txt EX-32.1 1520
  Complete submission text file 0000950135-04-003881.txt   401416
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 04961047
SIC: 2836 Biological Products, (No Diagnostic Substances)